A Study to Assess Efficacy and Safety Intravenous Benapenem in Patients With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)

Status:
Completed

Trial end date:
2020-05-08

Target enrollment:

Participant gender:

Phase 2/Phase 3

Sihuan Pharmaceutical Holdings Group Ltd.

Ertapenem